UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 19, 2017

Accession Number:	0001193125-17-002999
Submission Type:	POS AM
CIK: 0001341235 Company Name: Aldeyra Therapeutics, Inc. File Number: 333-203077